WGS

GeneDx Holdings Corp. Class A

WGS·81663L200·US·Common Stock·Healthcare - Diagnostics & Research-Activist

WGS (GeneDx Holdings Corp. Class A) is held by 120 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($117.1M), GOLDMAN SACHS GROUP INC ($114.6M), ARK Investment Management LLC ($110.5M). Net institutional sentiment: Mixed.

120
Holders
(11 Elite)
$1.2B
Total Value
55% (135)
Consensus
74 buying - 61 selling
13F: Insider & Congress: Updated regularly
WGS

Smart Money Verdict

View all
Loading verdict
Held by 120 funds
11 elite

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders Jun 18, 2026 · Activists Aug 11, 2026 · Congress none

ActivistTHE GOLDMAN SACHS GROUP, INC.THE GOLDMAN SACHS GROUP, INC.5.8%Aug 11, 2026
ActivistARK Investment Management LLCARK Investment Management LLC5.3%Aug 7, 2026
ActivistBlackRock, Inc.BlackRock, Inc.5.5%Jul 28, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
1.7M(+10.0%)$117.1M0.0%+11.09%
33
Increased
1.7M(+25.1%)$114.6M0.0%+13.87%
37
Increased
1.6M(+21.6%)$110.5M0.7%-0.51%
51
Increased
1.4M(+80.7%)$96.2M0.3%+15.80%
55
Increased
988,297(+85.7%)$67.8M0.0%+30.68%
46
Increased
879,003(+2.4%)$60.3M0.0%+17.59%
30
Increased
865,462(+33.7%)$59.4M0.0%+16.87%
38
Increased
666,581(+5.2%)$45.8M0.0%-9.36%
31
Increased
666,581(+4.3%)$45.7M0.6%-9.42%
43
Increased
552,125(+0.5%)$37.9M0.0%+122.92%
29
Increased
527,815(+11.7%)$36.2M0.0%+79.70%
32
Increased
457,201(+98.7%)$31.4M0.0%+23.95%
46
Increased
347,927(+2.0%)$23.9M0.0%+4.17%
29
Increased
346,211(+47.6%)$23.8M0.0%+13.72%
39
Increased
303,433(+219.0%)$20.8M0.0%+6.13%
46
Decreased
280,938(-53.7%)$19.3M0.0%-19.45%
0
Increased
280,619(+5.6%)$19.3M0.0%+10.56%
30
Increased
208,663(+310.6%)$14.3M0.0%+22.33%
45
Increased
207,664(+6.0%)$14.3M0.0%+7.96%
30
New
204,592$14M0.0%+31.51%
39

Showing 1-20 of 144

1 / 8
WGSWGSGeneDx Holdings Corp. Class A

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used